JP2000044485A - Active oxygen species scavenger and skin cosmetic - Google Patents
Active oxygen species scavenger and skin cosmeticInfo
- Publication number
- JP2000044485A JP2000044485A JP10211611A JP21161198A JP2000044485A JP 2000044485 A JP2000044485 A JP 2000044485A JP 10211611 A JP10211611 A JP 10211611A JP 21161198 A JP21161198 A JP 21161198A JP 2000044485 A JP2000044485 A JP 2000044485A
- Authority
- JP
- Japan
- Prior art keywords
- oxygen species
- skin
- active oxygen
- rice
- species scavenger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 50
- 239000001301 oxygen Substances 0.000 title claims abstract description 50
- 239000002516 radical scavenger Substances 0.000 title claims abstract description 24
- 239000002537 cosmetic Substances 0.000 title claims description 22
- 240000007594 Oryza sativa Species 0.000 claims abstract description 30
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 8
- 235000019441 ethanol Nutrition 0.000 claims abstract description 8
- 238000005498 polishing Methods 0.000 claims abstract description 6
- 235000013772 propylene glycol Nutrition 0.000 claims abstract description 3
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 23
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 20
- 235000007189 Oryza longistaminata Nutrition 0.000 claims description 17
- 235000021329 brown rice Nutrition 0.000 claims description 15
- 239000012046 mixed solvent Substances 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 36
- 239000000203 mixture Substances 0.000 abstract description 17
- 238000000605 extraction Methods 0.000 abstract description 14
- 235000009566 rice Nutrition 0.000 abstract description 12
- 230000009759 skin aging Effects 0.000 abstract description 5
- 206010010264 Condition aggravated Diseases 0.000 abstract description 3
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical compound CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 67
- 238000012360 testing method Methods 0.000 description 26
- 239000000243 solution Substances 0.000 description 19
- 238000011156 evaluation Methods 0.000 description 17
- 230000006872 improvement Effects 0.000 description 17
- -1 lipid peroxide Chemical class 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 13
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 13
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 9
- 239000012488 sample solution Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 230000008030 elimination Effects 0.000 description 8
- 238000003379 elimination reaction Methods 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 238000005502 peroxidation Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 241000746966 Zizania Species 0.000 description 2
- 235000002636 Zizania aquatica Nutrition 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000013040 bath agent Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- BUVFGIOGFDLYLM-UHFFFAOYSA-N (2-butylphenyl)methanol Chemical compound CCCCC1=CC=CC=C1CO BUVFGIOGFDLYLM-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
- BTVWZWFKMIUSGS-UHFFFAOYSA-N 2-methylpropane-1,2-diol Chemical compound CC(C)(O)CO BTVWZWFKMIUSGS-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- KCOZRKCEJGXIIF-UHFFFAOYSA-N CN(C)C1=C(C=CC=C1)N(C1=CC=CC=C1)[Na] Chemical compound CN(C)C1=C(C=CC=C1)N(C1=CC=CC=C1)[Na] KCOZRKCEJGXIIF-UHFFFAOYSA-N 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、活性酸素種消去剤
及び皮膚化粧料に関する。具体的には、疾病の増悪に深
く関与する過剰の生体内活性酸素種を消去することで生
体の恒常性維持に役立つ活性酸素種消去剤に関するもの
であり、日焼け等の外的刺激による皮膚の肌荒れ、シ
ワ、シミ、クスミ及び色素の異常沈着等皮膚の老化を予
防又は改善する効果に優れ、安全性においても優れた皮
膚化粧料に関するものである。TECHNICAL FIELD The present invention relates to a reactive oxygen species scavenger and a skin cosmetic. More specifically, it relates to a reactive oxygen species scavenger that helps maintain homeostasis by eliminating excess in vivo reactive oxygen species that are deeply involved in the exacerbation of disease. The present invention relates to a skin cosmetic having an excellent effect of preventing or improving skin aging such as rough skin, wrinkles, stains, blemishes and abnormal deposition of pigments, and also having excellent safety.
【0002】[0002]
【従来の技術】近年、老化と深く関わる活性酸素種が非
常に注目されている。活性酸素種とは、通常の酸素より
活性化された酸素種を意味し、特に生体に関連するもの
として、例えば、スーパーオキサイド(O2 -)、過酸化
水素(H2O2)、ヒドロキシラジカル(HO・)や一重
項酸素(1O2)などが挙げられる。2. Description of the Related Art In recent years, active oxygen species closely related to aging have been attracting much attention. The reactive oxygen species means oxygen species activated from ordinary oxygen, and particularly those related to living organisms such as superoxide (O 2 − ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical. (HO.) And singlet oxygen ( 1 O 2 ).
【0003】生体内に、細菌やウイルス、異物等が侵入
すると、白血球系の食細胞が活性化し、その結果各種の
活性酸素種を産生して、細菌やウイルス、異物等を攻撃
し、生体を係る外敵から防御する。When bacteria, viruses, foreign substances, and the like enter the living body, leukocyte phagocytes are activated, and as a result, various reactive oxygen species are produced, attacking bacteria, viruses, foreign substances, and the like, thereby damaging the living body. Defend against such external enemies.
【0004】しかし、近年になって、活性酸素種が生体
内に過剰に存在すると種々の障害をもたらすことが明ら
かになってきた。体内で産生され、他の活性酸素種の出
発物質ともなっているスーパーオキサイドは、消去酵素
であるスーパーオキサイドジムスターゼ(SOD)によ
り逐次消化されているが、スーパーオキサイドの産生が
過剰である場合やSODの活性が低下している場合に
は、活性酸素種の消去が不十分となり、より障害性の高
いH2O2やHO・の産生が過剰になり、これが関節リュ
ーマチやベーチェット病などの組織障害や心筋梗塞、脳
卒中、白内障などの疾病を引き起こすことが知られてい
る。However, in recent years, it has become clear that excessive existence of reactive oxygen species in a living body causes various obstacles. Superoxide, which is produced in the body and also serves as a starting material for other reactive oxygen species, is sequentially digested by superoxide dismutase (SOD), which is a scavenging enzyme. When the activity of HO is decreased, the elimination of reactive oxygen species becomes insufficient, and the production of more troublesome H 2 O 2 and HO. Becomes excessive, which causes tissue damage such as rheumatoid arthritis and Behcet's disease. It is known to cause diseases such as myocardial infarction, stroke, and cataract.
【0005】一方、皮膚は紫外線などの環境因子の刺激
を直接受けるため、活性酸素種を生成しやすい器官であ
り、活性酸素種の濃度上昇とそれに伴う過酸化脂質の生
成と合い重なって、様々な障害を引き起こし易い。[0005] On the other hand, the skin is directly affected by environmental factors such as ultraviolet rays, and is therefore an organ that easily produces reactive oxygen species. In combination with the increase in the concentration of reactive oxygen species and the production of lipid peroxide associated therewith, various factors are involved. Easy to cause serious obstacles.
【0006】例えば、炎症を生じたり紫外線を受けた皮
膚では、活性酸素種を発生することが知られており、こ
の活性酸素種による生体の酸化障害を避けるため、先に
述べたSODやカタラーゼ、グルタチオンパーオキシダ
ーゼ等の消去酵素が働くことで恒常性を保とうとする。For example, it is known that inflamed skin or skin exposed to ultraviolet rays generates reactive oxygen species. To avoid oxidative damage to living organisms caused by the reactive oxygen species, SOD, catalase, Attempts to maintain homeostasis by the action of scavenging enzymes such as glutathione peroxidase.
【0007】しかし、皮膚において過剰の活性酸素種が
消去されずに残留すると、これらが色素細胞であるメラ
ノサイトに働きかけて、メラニンの異常生成を促し、色
素沈着を促進したり、皮膚組織の正常な形状を保つため
に存在する細胞外マトリックスの構成成分であるエラス
チンやコラーゲンの架橋や断片化を促進し、皮膚の弾性
低下やシワを発生する。また過剰の活性酸素種は、皮膚
脂質であるスクワレンや細胞脂質膜を酸化することで細
胞の働きを低下させ、シミやシワ、肌荒れを増悪するこ
とが知られている。However, if excess reactive oxygen species remain in the skin without erasure, they act on melanocytes, which are pigment cells, to promote abnormal production of melanin, promote pigmentation, and to normalize skin tissues. It promotes the cross-linking and fragmentation of elastin and collagen, which are components of the extracellular matrix that exists to maintain the shape, and reduces the elasticity and wrinkles of the skin. Excessive reactive oxygen species are known to oxidize squalene, a skin lipid, and cell lipid membranes, thereby reducing the function of cells and exacerbating spots, wrinkles, and rough skin.
【0008】そこで、これら活性酸素種が引き起こす皮
膚老化作用を予防、改善するために、活性酸素種を消去
する成分の研究が進められ、生体成分である上記SOD
やグルタチオン、ビタミンC、ビタミンE、ビタミンB
2やブチルヒドロキシトルエン、ブチルヒドロキシアニ
ソールなどの合成物が見い出されたが、いずれも安定性
や安全性に難があり、より有用なものが求められてい
る。Therefore, in order to prevent and improve the skin aging effect caused by these reactive oxygen species, research on components for eliminating reactive oxygen species has been advanced, and the above-mentioned SOD which is a biological component has been studied.
And glutathione, vitamin C, vitamin E, vitamin B
Synthetic compounds such as 2, 2-butylhydroxytoluene, and butylhydroxyanisole have been found, but all have poor stability and safety, and more useful compounds have been demanded.
【0009】さらに近年においては、安全性を重視して
天然物である植物より活性酸素種消去成分を探索する試
みが広く行なわれ、ウワミズザクラのプルタソールA、
ユーカリ等のエラグ酸、大麦や黒米、黒インゲン等の穀
類のフラボノイド、茶のカテキン、ゴマのセサミン類、
セージやローズマリー等のハーブ類に含まれるカルノソ
ールやローズマノールなどが見い出されたが、いずれも
含有量や抽出溶媒への溶解性、安定性に難があり、また
効果も十分ではなく実用化するには満足できるものでは
なかった。In recent years, attempts have been made to search for active oxygen species-eliminating components from plants, which are natural products, with an emphasis on safety.
Ellagic acid such as eucalyptus, flavonoids of cereals such as barley, black rice and black beans, catechin of tea, sesamin of sesame,
Carnosol and rosemanol, etc., found in herbs such as sage and rosemary, have been found, but all have poor content, solubility in extraction solvents, and stability, and their effects are not sufficient, and they are not practical. Was not satisfactory.
【0010】さらにヒトが常食し、安全性が確認されて
いる米や米糠より活性酸素種消去成分を見い出す試みも
行なわれており、ワイルドライスから抽出されたケイ皮
酸誘導体類が活性酸素種消去効果を有することが見い出
されている(特開平8−26983号公報参照)。Attempts have also been made to find active oxygen species-eliminating components from rice and rice bran, which are normally eaten by humans and whose safety has been confirmed. Cinnamic acid derivatives extracted from wild rice are active oxygen species-eliminating. It has been found to have an effect (see JP-A-8-26983).
【0011】しかしながら、これらケイ皮酸誘導体類の
含有量は極めて少なく、またワイルドライスの商業的作
付けはほとんどないのが実情であり、実用に供するのは
非常に困難である。However, the content of these cinnamic acid derivatives is extremely low, and there is almost no commercial cropping of wild rice, so that it is very difficult to put them to practical use.
【0012】一方豊富に存在する白米の糠の熱水抽出物
について検討がなされているが(特開平8−15132
0号公報参照)、糠を熱水抽出した場合、抽出液が粥状
となって糠と抽出液の分離が極めて困難であるばかりで
なく、また得られた成分の抗酸化作用は確認されている
ものの活性酸素種消去効果についてはほとんど確認され
ていない。On the other hand, a study has been made on a hot water extract of abundant white rice bran (Japanese Patent Laid-Open No. 8-15132).
No. 0), when the bran is extracted with hot water, the extract becomes porridge and not only is extremely difficult to separate the bran and the extract, but also the antioxidant action of the obtained components has been confirmed. However, the effect of eliminating reactive oxygen species has hardly been confirmed.
【0013】[0013]
【発明が解決しようとする課題】本発明は上記課題に鑑
みてなされたものであり、その目的は安全性に優れ、か
つ疾病の増悪や皮膚の老化に関与する活性酸素種を消去
する作用に優れた活性酸素種消去剤を提供することにあ
る。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above problems, and has as its object to provide an excellent safety and an effect of eliminating active oxygen species involved in exacerbation of diseases and aging of skin. An object of the present invention is to provide an excellent active oxygen species eliminating agent.
【0014】また、本発明は上記活性酸素種消去剤を活
性成分として配合することにより、紫外線等の照射で生
じる皮膚の活性酸素種を消去して、シワやクスミ、シ
ミ、肌荒れ、肌の弾性の低下及び色素の異常沈着等皮膚
老化を予防、改善する効果に優れた皮膚化粧料を提供す
ることにある。In addition, the present invention eliminates active oxygen species of the skin caused by irradiation with ultraviolet rays or the like by blending the above active oxygen species scavenger as an active ingredient, thereby eliminating wrinkles, wrinkles, spots, rough skin, and elasticity of the skin. It is an object of the present invention to provide a skin cosmetic having an excellent effect of preventing and improving skin aging such as reduction of skin color and abnormal deposition of pigment.
【0015】[0015]
【課題を解決するための手段】本発明者らは、上記課題
を解決すべく鋭意研究を行った結果、赤米玄米や赤米玄
米を精米して得られる糠より、親水性有機溶媒又は親水
性有機溶媒と水との混合溶媒を用いて得られた抽出物
が、極めて高い活性酸素種消去作用を有することを見出
し、本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that a red organic brown rice or a bran obtained by polishing red rice brown rice is converted into a hydrophilic organic solvent or hydrophilic rice. The present inventors have found that an extract obtained by using a mixed solvent of a water-soluble organic solvent and water has an extremely high elimination action of active oxygen species, and have completed the present invention.
【0016】本発明に用いられる赤米とは、熱帯アジア
原産の水稲の1種であり、独特の赤色を呈し、赤飯のル
ーツとも言われ、中国等を通じて古くよりわが国に移入
され、今日まで食されていることが知られている。赤米
は、通常の白米とその起源をオリザ・サティバ(Oryza
Sativa)として共通するが、玄米の果皮や種皮に赤色系
色素を多量に含むことを特徴としており、この点で白米
と異なるものである。The red rice used in the present invention is a kind of rice that is native to tropical Asia, has a unique red color, is also called the roots of red rice, has been imported into Japan through China and other countries, and has been eaten to date. Is known to be. Red rice is derived from ordinary white rice and its origin, Oryza Sativa.
Although common as Sativa), it is characterized by a large amount of red pigment in the peel and seed coat of brown rice, which is different from white rice in this point.
【0017】本発明の活性酸素種消去剤を得る原料とし
ては、上述の赤米玄米や赤米玄米を精米して得られる糠
が用いられるが、これらはそれぞれ単独でもあるいは赤
米玄米とその糠とを適宜混合して用いてもよく、得られ
る活性酸素種消去剤の活性の強さや経済性を考えた場
合、精米して得られた赤米の糠を用いることが効率的で
ある。As a raw material for obtaining the active oxygen species scavenger of the present invention, the above-described red rice brown rice or bran obtained by polishing brown rice is used, either alone or in combination with red rice brown rice and its bran. May be used as appropriate, and in view of the activity and economical efficiency of the obtained active oxygen species scavenger, it is efficient to use red rice bran obtained by milling rice.
【0018】赤米玄米を抽出原料として用いる場合に
は、そのまま用いてもよいが、抽出効率を上げるために
粗砕を行うのがよい。一方、赤米の糠を用いる場合に
は、そのまま抽出原料として用いることができる。When brown rice is used as an extraction raw material, it may be used as it is, but it is preferable to carry out crushing in order to increase the extraction efficiency. On the other hand, when red rice bran is used, it can be used as an extraction raw material as it is.
【0019】本発明の活性酸素種消去剤は、これらを抽
出原料として、通常のエキス剤や浸剤等の抽出物を得る
のと同様、抽出原料に適当な抽出溶媒を加えて抽出する
ことができる。これらの抽出原料より活性酸素種消去剤
を抽出するのに使用できる溶媒としては、親水性有機溶
媒、すなわち水と混合することのできる各種の有機溶媒
を用いることができ、例えば、メチルアルコール、エチ
ルアルコール、グリセリン、1,3−ブチレングリコー
ル、プロピレングリコール、ジプロピレングリコール、
イソブチレングリコールあるいはこれらの親水性有機溶
媒を挙げることができる。また、これらの2種以上の親
水性有機溶媒を適宜混合したり、さらにこれらの1種若
しくは2種以上の親水性有機溶媒と水を適宜混合して用
いることもできる。この時、親水性有機溶媒と水の混合
比率は任意に設定できるが、好ましくは重量比で7:3
〜1:9の範囲とし、親水性有機溶媒単独よりも水との
混合溶媒を用いるのが好ましい。The active oxygen species-eliminating agent of the present invention can be extracted by adding an appropriate extraction solvent to the extraction raw material in the same manner as when using these as the extraction raw material to obtain an extract such as a usual extractant or impregnating agent. . As the solvent that can be used to extract the active oxygen species-eliminating agent from these extraction raw materials, hydrophilic organic solvents, that is, various organic solvents that can be mixed with water, for example, methyl alcohol, ethyl Alcohol, glycerin, 1,3-butylene glycol, propylene glycol, dipropylene glycol,
Examples thereof include isobutylene glycol and a hydrophilic organic solvent thereof. Further, two or more of these hydrophilic organic solvents may be appropriately mixed, or one or two or more of these hydrophilic organic solvents and water may be appropriately mixed and used. At this time, the mixing ratio of the hydrophilic organic solvent and water can be arbitrarily set, but is preferably 7: 3 by weight.
It is preferable to use a mixed solvent with water rather than a hydrophilic organic solvent alone.
【0020】また、これらの溶媒で抽出するに当たり、
抽出原料を予めヘキサン等の非極性溶媒を用いて脱脂し
ておくのが好都合であり、活性成分をさらに効率よく抽
出することができる。In extracting with these solvents,
It is convenient to previously degrease the extraction raw material using a nonpolar solvent such as hexane, so that the active ingredient can be extracted more efficiently.
【0021】抽出は、赤米玄米及び/又は糠に対し重量
比で5〜15倍程度の抽出溶媒を加えて浸漬し、常温乃
至100℃程度の加温下で、数〜十数時間程度ゆるく撹
拌、混合しながら、可溶性成分を十分に溶出させる。そ
の後、ろ紙やろ布によるろ過あるいはフィルタープレ
ス、遠心分離等の公知の固液分離法を用いて固液分離を
行い、活性酸素種消去成分を含有する抽出液を得る。The extraction is carried out by adding an extraction solvent in a weight ratio of about 5 to 15 times with respect to red rice brown rice and / or bran, immersing the mixture, and gently loosening the mixture at room temperature to about 100 ° C. for several to several tens of hours. While stirring and mixing, the soluble components are sufficiently eluted. Thereafter, solid-liquid separation is performed using a known solid-liquid separation method such as filtration with a filter paper or filter cloth, filter press, or centrifugation to obtain an extract containing an active oxygen species-eliminating component.
【0022】得られた抽出液は、そのまま本発明の活性
酸素種消去剤として用いることができるが、溶媒を留去
して、ペースト状物やさらに乾燥を行った固形状物とす
ることもできる。また、活性成分を失わない程度に活性
炭等で抽出液を、簡単な脱臭・脱色処理を施すこともで
きる。さらに以下に述べるような使用目的・使用方法に
応じて使用しやすいよう、活性酸素種消去効果を失わな
い程度に、適宜各種デンプンや乳糖等のいわゆる賦形剤
を添加して、本発明の活性酸素種消去剤とすることもで
きる。The obtained extract can be used as it is as an active oxygen species eliminating agent of the present invention. However, the solvent can be distilled off to obtain a paste or a dried solid. . In addition, the extract can be subjected to simple deodorizing and decoloring treatment with activated carbon or the like to the extent that active ingredients are not lost. Further, so-called excipients such as various starches and lactose are appropriately added to such an extent that the active oxygen species elimination effect is not lost so as to be easily used according to the purpose of use and the method of use as described below, and the activity of the present invention is improved. An oxygen species scavenger can also be used.
【0023】このようにして得られる本発明の活性酸素
種消去剤の活性成分(本質)は明らかではないが、合成
高分子吸着体であるダイヤイオンCHP−20やセファ
デックスLH−20等のカラムクロマトグラフィ−で分
離・分画を行って得られた活性画分を、核磁気共鳴(N
MR)スペクトル法で確認した結果、活性成分(画分)
の一部に、フラバンを基本骨格とした重合体であるプロ
アントシアニジンを確認することができたが、ケイ皮酸
誘導体は確認できなかった。Although the active component (essence) of the active oxygen species scavenger of the present invention thus obtained is not clear, columns such as Diaion CHP-20 and Sephadex LH-20 which are synthetic polymer adsorbents are used. The active fraction obtained by separation and fractionation by chromatography is analyzed by nuclear magnetic resonance (N
As a result of confirming by MR) spectral method, active ingredient (fraction)
In some of them, proanthocyanidins, which are polymers having flavan as a basic skeleton, could be confirmed, but cinnamic acid derivatives could not be confirmed.
【0024】本発明の活性酸素種消去剤は、既に述べた
ように古来主食として利用してきた赤米を原料としたも
のであって、その安全性は確認されている。また、異味
・異臭も極めて弱いため、一般的な飲食品、例えば、清
涼飲料水、茶飲料、乳製品、野菜果実加工品、菓子等に
用いることができ、これらを製造するに当たり、通常用
いられる原料や添加物、例えばブドウ糖や果糖、蔗糖等
の糖類、クエン酸やリンゴ酸等の有機酸類、ビタミンB
群やビタミンC(L−アスコルビン酸)、ビタミンE等
のビタミン類、グリセリンやプロピレングリコール、ソ
ルビトール等の多価アルコール類、グリセリン脂肪酸エ
ステル、ショ糖脂肪酸等の界面活性剤、その他カラギー
ナン、カゼイン、ゼラチン、ペクチン、寒天、アミノ
酸、カルシウム塩類、色素、香料、保存料などと共に使
用することができる。The active oxygen species scavenger of the present invention is made from red rice, which has been used as a staple food since ancient times, as described above, and its safety has been confirmed. In addition, since off-flavors and off-flavors are extremely weak, they can be used in general foods and drinks, for example, soft drinks, tea drinks, dairy products, processed vegetable and fruit products, confectionery, etc., and are usually used in producing these. Raw materials and additives, such as sugars such as glucose, fructose, and sucrose; organic acids such as citric acid and malic acid; vitamin B
Group, vitamin C (L-ascorbic acid), vitamins such as vitamin E, polyhydric alcohols such as glycerin, propylene glycol and sorbitol, surfactants such as glycerin fatty acid ester and sucrose fatty acid, other carrageenan, casein and gelatin , Pectin, agar, amino acids, calcium salts, pigments, flavors, preservatives and the like.
【0025】また、本発明の活性酸素種消去剤は、健康
食品、医薬品としても使用できる他、化粧品等に配合し
て前記した過剰に存在する生体内活性酸素種による種々
の障害を予防・改善するなど、広範囲に利用することが
できる。Further, the active oxygen species scavenger of the present invention can be used as health foods and pharmaceuticals, and can be added to cosmetics and the like to prevent / improve various obstacles caused by the excessively present in vivo active oxygen species. It can be widely used.
【0026】好適な使用量としては、添加対象によって
も異なるが、食品や健康食品の場合には、本発明の活性
酸素種消去剤を抽出乾燥物として前記食品中0.01〜
20重量%である。The preferred amount of use varies depending on the object to be added, but in the case of foods and health foods, the active oxygen species scavenger of the present invention is used as an extract and dried product in an amount of from 0.01 to 0.01%.
20% by weight.
【0027】さらに、本発明の活性酸素種消去剤は経皮
的に吸収され、効果を示すため、最も有効に利用するた
めには、皮膚化粧料に配合することである。配合対象と
して適当な皮膚化粧料として、例えば、軟膏、クリー
ム、乳液、ローション、パック、入浴剤等を挙げること
ができる。また、これらの皮膚化粧料には、本発明の活
性酸素種消去剤を抽出乾燥物として、化粧料中0.00
1〜10重量%配合することで、効果を得ることができ
る。Furthermore, the active oxygen species-eliminating agent of the present invention is absorbed transdermally and exhibits an effect. Therefore, in order to utilize it most effectively, it is to be incorporated into a skin cosmetic. Suitable skin cosmetics to be compounded include, for example, ointments, creams, emulsions, lotions, packs, bath preparations and the like. In addition, these skin cosmetics contain the active oxygen species-eliminating agent of the present invention as an extracted and dried product in an amount of 0.00
The effect can be obtained by mixing 1 to 10% by weight.
【0028】本発明に係る皮膚化粧料は、皮膚に塗布す
ることによって、紫外線等の外的刺激により産生する過
剰の活性酸素種を速やかに消去し、皮膚の老化、特にシ
ワやシミ、タルミやクスミ、肌荒れ及び色素の異常沈着
等を予防・改善することができる。The skin cosmetic according to the present invention, when applied to the skin, quickly eliminates excess reactive oxygen species produced by external stimuli such as ultraviolet rays, and aging of the skin, especially wrinkles, spots, tarmi and the like. It can prevent and improve blemishes, rough skin, abnormal pigment deposition, and the like.
【0029】本発明に係る皮膚化粧料は、通常の皮膚化
粧料と同様の原料を用いることができ、当該原料とし
て、例えばアボガド油、コメヌカ油、コメ胚芽油、ラノ
リン、スクワラン等の油性成分、グリセリン、1,3−
ブチレングリコール、コラーゲン、ヒアルロン酸及びそ
の塩、コンドロイチン硫酸及びその塩、キトサン、キチ
ン等の保湿剤、グリセロリン脂質、スフィンゴリン脂
質、グリセロ糖脂質などの複合脂質、SOD、カタラー
ゼ、β−カロチン、イチヨウ抽出物、ビタミンC及びそ
の誘導体、ビタミンE及びその誘導体、オウゴン抽出
物、クジン抽出物等の活性酸素種消去作用成分、グアイ
アズレン及びその誘導体やカマアズレン及びその誘導
体、グリチルリチン酸及びその塩やグリチルレチン酸及
びその塩、グリチルレチン酸誘導体、酸化亜鉛等の抗炎
症剤、その他各種植物抽出物、増粘剤、防腐剤、紫外線
吸収剤、香料、酸化防止剤、水、各種アルコール等が挙
げられる。The skin cosmetics according to the present invention can use the same raw materials as ordinary skin cosmetics. Examples of the raw materials include oily components such as avocado oil, rice bran oil, rice germ oil, lanolin, squalane, and the like. Glycerin, 1,3-
Moisturizers such as butylene glycol, collagen, hyaluronic acid and its salts, chondroitin sulfate and its salts, chitosan, chitin, etc., complex lipids such as glycerophospholipid, sphingolipid, and glyceroglycolipid, SOD, catalase, β-carotene, and Ichiyo extract Substances, vitamin C and its derivatives, vitamin E and its derivatives, gongo extract, kujin extract and other active oxygen species-eliminating active ingredients, guaiazulene and its derivatives, kamaazulene and its derivatives, glycyrrhizic acid and its salts, and glycyrrhetinic acid and its Salts, glycyrrhetinic acid derivatives, anti-inflammatory agents such as zinc oxide, and other various plant extracts, thickeners, preservatives, ultraviolet absorbers, fragrances, antioxidants, water, various alcohols, and the like.
【0030】[0030]
【実施例】以下、本発明の実施例に基づいてさらに詳細
に説明する。 (実施例1)赤米玄米を粗砕したもの10kgに、30
重量%のエタノール水溶液100lを加えて加熱し、還
流冷却下で5時間抽出した。得られた抽出液をろ紙ろ過
し、ろ液を減圧下で濃縮し、残ったペースト状物を凍結
乾燥して、本発明の活性酸素種消去剤である乾燥物28
0gを得た。DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described in more detail based on embodiments. (Example 1) 30 kg to 10 kg of crushed red rice brown rice
A 100% by weight aqueous ethanol solution was added, heated, and extracted under reflux cooling for 5 hours. The obtained extract is filtered through filter paper, the filtrate is concentrated under reduced pressure, and the remaining paste is freeze-dried to obtain a dried product 28 which is the active oxygen species scavenger of the present invention.
0 g was obtained.
【0031】(実施例2)赤米玄米を精米して得た糠1
0kgに、n−ヘキサン100lを加えて、50℃に加
温しながら2時間ゆるく撹拌を行い、糠の油脂を抽出
し、ろ紙ろ過により固液分離を行った。その後、残渣に
n−ヘキサン100lを加えて先と同様の操作を行い、
さらに油脂を除去し、得られた残渣について溶媒を減圧
留去した。得られた残渣に90重量%のエタノール水溶
液100lを加え、室温下でゆるく撹拌を行いながら1
0時間抽出し、ろ紙ろ過により抽出液を得た。当該抽出
液を減圧下で濃縮し、残ったペースト状物を凍結乾燥し
て、本発明の活性酸素種消去剤である乾燥物730gを
得た。Example 2 Bran 1 obtained by milling red rice brown rice
To 0 kg, 100 l of n-hexane was added, and the mixture was slowly stirred for 2 hours while heating to 50 ° C. to extract the oil and fat of bran, followed by solid-liquid separation by filter paper filtration. Thereafter, 100 l of n-hexane was added to the residue, and the same operation as above was performed.
Further, fats and oils were removed, and the solvent was distilled off from the obtained residue under reduced pressure. 100 l of a 90% by weight aqueous ethanol solution is added to the obtained residue, and the mixture is stirred at room temperature with gentle stirring.
Extraction was performed for 0 hours, and an extract was obtained by filtration through a filter paper. The extract was concentrated under reduced pressure, and the remaining paste was freeze-dried to obtain 730 g of a dried product that was the active oxygen species eliminating agent of the present invention.
【0032】(実施例3)実施例2と同様にして得られ
た脱脂赤米糠全量に、50重量%の1,3−ブチレング
リコールの水溶液70lを加え、95℃の加熱下ゆるく
撹拌を行いながら5時間抽出し、ろ紙ろ過を行った。そ
の後、抽出液を5℃下で5日間放置した後、生じたおり
や沈殿をケイソウ土を用いてろ過除去し、本発明の活性
酸素種消去剤である澄明な抽出液43lを得た。なお、
得られた抽出液を減圧乾固させ、抽出液中の固形分を測
定した結果は、1.06重量%であった。Example 3 To a total amount of defatted red rice bran obtained in the same manner as in Example 2, 70 l of an aqueous solution of 50% by weight of 1,3-butylene glycol was added, and the mixture was slowly stirred under heating at 95 ° C. Extraction was performed for 5 hours, and filtration with filter paper was performed. Thereafter, the extract was allowed to stand at 5 ° C. for 5 days, and the generated cages and precipitates were removed by filtration using diatomaceous earth to obtain 43 l of a clear extract which was the active oxygen species eliminating agent of the present invention. In addition,
The obtained extract was dried under reduced pressure, and the solid content in the extract was measured. The result was 1.06% by weight.
【0033】〔活性酸素種消去作用〕次に実施例1及び
実施例2で得た乾燥物の活性酸素種消去作用について、
以下に示す方法で、SOD様活性作用(NBT法)、一
重項酸素による脂質膜の過酸化抑制作用、過酸化水素消
去作用、DPPHに対するラジカル消去作用についてそ
れぞれ試験を行った。なお、各試験においては、上記抽
出物を適当な濃度となるように水又はPBSに溶解若し
くは懸濁させ、濃度の異なる数段階の試料溶液を用いて
試験を行い、それぞれの試験について消去率(あるいは
抑制率)が50%となる作用濃度を求めた。また、比較
例として、白米(コシヒカリ)玄米を精米して得た糠に
ついて実施例2と同様の操作で得た抽出乾燥物を用い
た。[Effect of elimination of active oxygen species] Next, the elimination of active oxygen species of the dried products obtained in Examples 1 and 2 will be described.
Tests were performed on the SOD-like activity (NBT method), the lipid membrane peroxidation inhibitory action by singlet oxygen, the hydrogen peroxide scavenging action, and the radical scavenging action on DPPH by the following methods. In each test, the above extract was dissolved or suspended in water or PBS so as to have an appropriate concentration, and the test was performed using sample solutions of several concentrations having different concentrations. Alternatively, an action concentration at which the inhibition rate was 50% was determined. As a comparative example, an extract and dried product obtained by the same operation as in Example 2 was used for bran obtained by polishing white rice (Koshihikari) brown rice.
【0034】1.SOD様活性試験(NBT法) 試験管に、0.05M Na2CO3緩衝液(pH10.
2)2.4ml、3mM Xanthine0.1m
l、3mM EDTA(エチレンジアミン四酢酸ナトリ
ウム)0.1ml、BSA(牛血清アルブミン)溶液
0.1ml及び0.75mM NBT(ニトロブルーテ
トラゾリウム)0.1mlを加え、これに試料溶液0.
1mlを加えて25℃で10分間放置する。次いで、X
anthine Oxidase溶液0.1mlを加え
素早く撹拌し、25℃で20分間インキュベーションす
る。その後に6mM Cucl2 0.1mlを加えて
反応を停止させ、560nmでの吸光度Stを測定す
る。測定対照として、試料溶液の代わりに蒸留水を用い
て同様に操作し、吸光度Btを測定する。また、試料溶
液のブランク及び比較対照のブランクとして、それぞれ
Xanthine Oxidase溶液の代わりに蒸留
水を用いて同様に操作し吸光度So及び吸光度Boを測
定し、次の式1よりSOD様活性抑制率を算出する。 抑制率(%)=〔1−{(St−So)/(Bt−Bo)}〕×100 ・・・(式1) なお、Xanthine Oxidase溶液は、Xa
nthine Oxidase(ベーリンガー社製)を
蒸留水で約100倍に希釈し、上記同様の操作を行った
際、測定対照の吸光度Btが0.20〜0.23の範囲
に入るように調整する。1. SOD-like activity test (NBT method) A 0.05 M Na 2 CO 3 buffer solution (pH 10.
2) 2.4 ml, 3 mM Xanthine 0.1 m
Then, 0.1 ml of 3 mM EDTA (sodium ethylenediaminetetraacetate), 0.1 ml of BSA (bovine serum albumin) solution and 0.1 ml of 0.75 mM NBT (nitro blue tetrazolium) were added thereto, and 0.1 ml of the sample solution was added.
Add 1 ml and leave at 25 ° C. for 10 minutes. Then X
Add 0.1 ml of anthine oxidase solution, stir quickly, and incubate at 25 ° C for 20 minutes. Thereafter, 0.1 ml of 6 mM CuCl 2 is added to stop the reaction, and the absorbance St at 560 nm is measured. As a measurement control, the same operation is performed using distilled water instead of the sample solution, and the absorbance Bt is measured. In addition, as a sample solution blank and a control blank, the same operation was performed using distilled water instead of the Xanthine Oxidase solution, and the absorbance So and the absorbance Bo were measured, and the SOD-like activity inhibition rate was calculated from the following equation 1. I do. Suppression rate (%) = [1-{(St-So) / (Bt-Bo)}] × 100 (Equation 1) The Xanthine Oxidase solution is Xa
nthine Oxidase (manufactured by Boehringer) is diluted about 100-fold with distilled water, and the same operation as above is performed so that the absorbance Bt of the measurement control falls within the range of 0.20 to 0.23.
【0035】2.一重項酸素による膜脂質の過酸化抑制
試験(赤血球溶血試験) 透明なガラス製の10mlサンプルビンに、2%RBC
懸濁液5ml、試料をそれぞれの濃度で含むPBS溶液
(pH7.0の等張リン酸緩衝液)5ml及び光増感剤
(10mMヘマトポルフィリン−20mM水酸化ナトリ
ウム溶液)0.01mlを加え、よく混和する。この反
応溶液をメリーゴーランド上、7.5Wハロゲンランプ
で35分間均一に光照射して一重項酸素を発生させ、赤
血球を溶血させる。この反応溶液1mlを採取し、PB
S2mlを加えよく撹拌し、その後、4℃、3000r
pmで5分間遠心分離した後、上清について波長540
nmでの吸光度SAを測定する。一方、対照溶液とし
て、試料を加えないPBS溶液5mlを用いて同様に操
作して完全に溶血させた反応溶液を得、当該反応溶液1
mlについてさらに上記と同様に操作して、波長540
nmでの吸光度SBを測定し、次の式2により、過酸化
抑制率を算出する。 過酸化抑制率(%)={(SB−SA)/SB}×100 ・・・(式2) なお、RBC懸濁液は次の方法により得られたものを用
いた。ウサギから採血して得たヘパリン血10〜20m
lを、ガラス玉5個入りの50ml三角フラスコに入れ
10分間軽く回す。数分間放置してフィブリンが析出し
た脱繊維素血を得る。これを4℃、3000rpmで1
0分間遠心分離を行い上清を除去した後、PBS3ml
を加え4℃、3000rpmで10分間遠心分離して、
洗浄を十分に繰り返し(3回程度)、洗浄されたRBC
(赤血球)を得る。当該RBCに所定量のPBSを加
え、2%のRBC懸濁液とする。2. Test for inhibition of membrane lipid peroxidation by singlet oxygen (erythrocyte hemolysis test) 2% RBC in a clear glass 10 ml sample bottle
5 ml of the suspension, 5 ml of a PBS solution (pH 7.0 isotonic phosphate buffer) containing the sample at each concentration and 0.01 ml of a photosensitizer (10 mM hematoporphyrin-20 mM sodium hydroxide solution) were added. Mix. The reaction solution is uniformly irradiated with light on a merry-go-round for 35 minutes with a 7.5 W halogen lamp to generate singlet oxygen and lyse red blood cells. 1 ml of this reaction solution is collected and PB
Add 2 ml of S and stir well.
After centrifugation at pm for 5 minutes, the supernatant
Measure absorbance SA in nm. On the other hand, as a control solution, a completely hemolyzed reaction solution was obtained by the same operation using 5 ml of a PBS solution to which no sample was added.
ml and operating at 540
The absorbance SB in nm is measured, and the peroxidation inhibition rate is calculated by the following equation 2. Peroxidation inhibition rate (%) = {(SB-SA) / SB} × 100 (Formula 2) The RBC suspension used was obtained by the following method. Heparin blood obtained by collecting blood from rabbits 10 to 20 m
1 is placed in a 50 ml Erlenmeyer flask containing 5 glass beads and gently rotated for 10 minutes. Leave for several minutes to obtain defibrinated blood with fibrin deposited. This is added at 4 ° C and 3000 rpm for 1 hour.
After centrifugation for 0 minutes to remove the supernatant, PBS 3 ml
And centrifuged at 3000 rpm for 10 minutes at 4 ° C.
Washing is repeated enough (about 3 times), and washed RBC
(Red blood cells). A predetermined amount of PBS is added to the RBC to make a 2% RBC suspension.
【0036】3.過酸化水素消去試験 過酸化水素の標準溶液(1.5mM)10μlに試料溶
液10μlを加え、37℃で20分間インキュベートし
た後に、発色溶液2.98mlを加え、37℃、5分間
インキュベートする。当該溶液について727nmでの
吸光度Stを測定する。また、比較対照として、試料溶
液の代わりに蒸留水を用いて同様に操作して、吸光度S
bを測定する。このとき、ブランクとして、発色溶液を
加えた後直ちに727nmでの吸光度Sto及びSbo
を測定しておき、次の式3により、過酸化水素の消去率
を測定する。 消去率(%)=〔1−{(St−Sto)/(Sb−Sbo)}〕×100 ・・・(式3) なお、発色溶液は、DA−64(N−(カルボキシメチ
ルアミノカルボニル)−4,4´−ビス(ジメチルアミ
ノ)−ジフェニルアミノナトリウム:和光純薬社製)を
100μM及びtritonX−100を0.5w/v
%を含む0.1MPIPES(ピペラジン−N,N´−
ビス(2−エタンスルホン酸))緩衝液(pH7.0)
にペルオキシダーゼ(100units/mg:和光純
薬社製)1mgを加えて溶解し、100mlとしたもの
を用いた。3. Hydrogen peroxide elimination test 10 μl of a sample solution is added to 10 μl of a standard solution (1.5 mM) of hydrogen peroxide, and the mixture is incubated at 37 ° C. for 20 minutes. Then, 2.98 ml of a coloring solution is added, and the mixture is incubated at 37 ° C. for 5 minutes. The absorbance St at 727 nm of the solution is measured. As a comparative control, the same operation was performed using distilled water instead of the sample solution to obtain an absorbance S
Measure b. At this time, as a blank, the absorbances Sto and Sbo at 727 nm immediately after the coloring solution was added.
Is measured, and the elimination rate of hydrogen peroxide is measured by the following equation (3). Erasure rate (%) = [1-{(St-Sto) / (Sb-Sbo)}] × 100 (Equation 3) The coloring solution is DA-64 (N- (carboxymethylaminocarbonyl) 100 μM of -4,4′-bis (dimethylamino) -diphenylaminosodium (manufactured by Wako Pure Chemical Industries) and 0.5 w / v of triton X-100.
% MPIPES (piperazine-N, N'-
Bis (2-ethanesulfonic acid)) buffer (pH 7.0)
1 mg of peroxidase (100 units / mg: manufactured by Wako Pure Chemical Industries, Ltd.) was added and dissolved to make 100 ml.
【0037】4.DPPHに対するラジカル消去試験 1.5×10-4MDPPH(α,α−ジフェニル−β−
ピクリルヒドラジル)のエタノール溶液3mlに試料溶
液3mlを加え密栓した後振り混ぜ、30分間放置す
る。放置後、520nmでの吸光度Stを測定する。ま
た、対照試験として、試料溶液の代わりに蒸留水を用い
て同様に操作し、520nmでの吸光度Sbを測定す
る。また、ブランクとして、DPPHのエタノール溶液
3mlに試料溶液3mlを加えた後直ちに520nmで
の吸光度Soを測定し、次の式4により、ラジカル消去
率を算出する。 ラジカル消去率=〔{Sb−(St−So)}/Sb〕×100 ・・・(式4)4. Radical scavenging test for DPPH 1.5 × 10 -4 MDPPH (α, α-diphenyl-β-
3 ml of a sample solution is added to 3 ml of an ethanol solution of (picrylhydrazyl), sealed, shaken, and left to stand for 30 minutes. After standing, the absorbance St at 520 nm is measured. In addition, as a control test, the same operation is performed using distilled water instead of the sample solution, and the absorbance Sb at 520 nm is measured. Also, as a blank, immediately after adding 3 ml of the sample solution to 3 ml of the ethanol solution of DPPH, the absorbance So at 520 nm is measured, and the radical scavenging rate is calculated by the following equation 4. Radical scavenging rate = [{Sb− (St−So)} / Sb] × 100 (Equation 4)
【0038】〔試験結果〕上記各試験結果を表1にまと
めた。表1から分かるように、本発明において活性酸素
種が消去されることが確認され、白米の糠の抽出物の活
性酸素種消去効果よりも極めて高いことが確認された。[Test Results] The results of the above tests are summarized in Table 1. As can be seen from Table 1, it was confirmed that the reactive oxygen species were eliminated in the present invention, and it was confirmed that the active oxygen species eliminating effect of the extract of white rice bran was extremely higher.
【0039】[0039]
【表1】 [Table 1]
【0040】次に、上記各実施例で得られた活性酸素種
消去剤を用いて各種の皮膚化粧料を作製し、当該皮膚化
粧料の内、乳液について使用試験を行った。 (処方例1)乳液 成 分 配合量(重量%) 実施例2の活性酸素種消去剤 1.0 1,3−ブチレングリコール 5.0 カルボキシビニルポリマー 0.13 ホホバ油 3.0 スクワラン 2.0 メチルフェニルポリシロキサン 3.0 ポリオキシエチレンセチルエーテル(1E.O.) 1.2 ショ糖脂肪酸エステル(HLB4) 0.5 ポリオキシエチレン硬化ヒマシ油(50E.O.) 1.5 トコフェロール 0.15 パラオキシ安息香酸エステル 0.2 L−アルギニン 0.13 精製水 適 量 (製造方法)上記成分の内、ホホバ油からパラオキシ安
息香酸エステルまでの8成分を加熱して、均一に溶解し
油相とする。残る成分を加熱して均一に溶解して水相と
し、撹拌しながら前記油相を水相に加え均一に乳化した
後、徐々に冷却して本発明の皮膚化粧料である乳液を得
る。Next, various skin cosmetics were prepared using the active oxygen species eliminating agent obtained in each of the above examples, and a use test was conducted on the emulsion of the skin cosmetics. (Formulation Example 1) Emulsion component Content (% by weight) Active oxygen species scavenger of Example 2 1.0 1,3-butylene glycol 5.0 Carboxyvinyl polymer 0.13 Jojoba oil 3.0 Squalane 2.0 Methylphenyl polysiloxane 3.0 Polyoxyethylene cetyl ether (1EO) 1.2 Sucrose fatty acid ester (HLB4) 0.5 Polyoxyethylene hydrogenated castor oil (50EO) 1.5 Tocopherol 0.15 Paraoxybenzoate 0.2 L-arginine 0.13 Purified water qs (Production method) Among the above components, eight components from jojoba oil to paraoxybenzoate are heated and uniformly dissolved to form an oil phase. . The remaining components are heated to be uniformly dissolved to form an aqueous phase, and the oil phase is added to the aqueous phase with stirring to emulsify uniformly, and then gradually cooled to obtain an emulsion as the skin cosmetic of the present invention.
【0041】 (処方例2)クリーム 成 分 配合量(重量%) 実施例1の活性酸素種消去剤 4.0 グリセリン 5.0 セチルアルコール 4.0 ステアリン酸 3.0 スクワラン 10.0 親油型モノステアリン酸グリセリル 2.0 セスキオレイン酸ソルビタン 1.0 ポリオキシエチレン硬化ヒマシ油(50E.O.) 1.5 トコフェロール 0.15 カルボキシビニルポリマー 0.1 水酸化カリウム 0.05 パラオキシ安息香酸エステル 0.2 精製水 適 量 (製造方法)セチルアルコール以下トコフェロールまで
の7成分を加熱して均一に溶解して油相とする。残る成
分を加熱して均一に溶解して水相とし、撹拌しながら前
記油相を水相に加え均一に乳化した後、その後徐々に冷
却して本発明の皮膚化粧料であるクリームを得る。(Formulation Example 2) Cream component Blending amount (% by weight) Active oxygen species scavenger of Example 1 4.0 Glycerin 5.0 Cetyl alcohol 4.0 Stearic acid 3.0 Squalane 10.0 Lipophilic type Glyceryl monostearate 2.0 Sorbitan sesquioleate 1.0 Polyoxyethylene hydrogenated castor oil (50 EO) 1.5 Tocopherol 0.15 Carboxyvinyl polymer 0.1 Potassium hydroxide 0.05 Paraoxybenzoate 0 2.2 Appropriate amount of purified water (Production method) Seven components from cetyl alcohol to tocopherol are heated and uniformly dissolved to form an oil phase. The remaining components are heated to be uniformly dissolved to form an aqueous phase, and the oil phase is added to the aqueous phase with stirring to emulsify uniformly, and then gradually cooled to obtain the cream, which is the skin cosmetic of the present invention.
【0042】 (処方例3)化粧水 成 分 配合量(重量%) 実施例3の活性酸素種消去剤 6.0 グリセリン 3.0 1,3−ブチレングリコール 4.0 モノラウリン酸 ポリオキシエチレンソルビタン(20E.O.) 0.5 無水クエン酸 0.01 パラオキシ安息香酸エステル 0.1 精製水 適 量 (製造方法)上記成分を取り、均一に溶解して本発明の
皮膚化粧料である化粧水を得る。(Formulation Example 3) Lotion lotion component content (% by weight) Active oxygen species scavenger of Example 3 6.0 glycerin 3.0 1,3-butylene glycol 4.0 monolauric acid polyoxyethylene sorbitan ( 20EO) 0.5 Citric anhydride 0.01 Paraoxybenzoate 0.1 Purified water Appropriate amount (Production method) Take the above-mentioned components and dissolve them uniformly to obtain a lotion as the skin cosmetic of the present invention. obtain.
【0043】 (処方例4)パック剤 成 分 配合量(重量%) 実施例2の活性酸素種消去剤 2.0 ステアリン酸 5.0 セチルアルコール 4.0 セスキオレイン酸ソルビタン 1.0 モノラウリン酸 ポリオキシエチレンソルビタン(20E.O.) 2.5 トコフェロール 0.15 自己乳化型モノステアリン酸グリセリル 4.0 スクワラン 15.0 カオリン 5.0 タルク 5.0 1,3−ブチレングリコール 5.0 グリセリン 3.0 キサンタンガム 0.2 パラオキシ安息香酸エステル 0.2 精製水 適 量 (製造方法)ステアリン酸以下スクワランまでの7成分
を加熱して均一に溶解して油相とする。残る成分を加熱
して均一に溶解して水相とし、撹拌しながら前記油相を
水相に加え均一に乳化した後、その後徐々に冷却し、カ
オリン及びタルクを加えて均一に混合した後、本発明の
皮膚化粧料であるパックを得る。(Formulation Example 4) Packing agent Component Compounding amount (% by weight) Active oxygen species scavenger of Example 2 2.0 Stearic acid 5.0 Cetyl alcohol 4.0 Sorbitan sesquioleate 1.0 Monolauric acid Poly Oxyethylene sorbitan (20EO) 2.5 Tocopherol 0.15 Self-emulsifying glyceryl monostearate 4.0 Squalane 15.0 Kaolin 5.0 Talc 5.0 1,3-butylene glycol 5.0 Glycerin 3.0. 0 Xanthan gum 0.2 Paraoxybenzoate 0.2 Purified water Adequate amount (Production method) The seven components from stearic acid to squalane are heated and uniformly dissolved to form an oil phase. The remaining components are heated and uniformly dissolved to form an aqueous phase.After stirring, the oil phase is added to the aqueous phase and uniformly emulsified, and then gradually cooled, and then kaolin and talc are added and uniformly mixed. A pack which is the skin cosmetic of the present invention is obtained.
【0044】 (処方例5)入浴剤 成 分 配合量(重量%) 実施例1の活性酸素種消去剤 1.0 オレイルアルコール 10.0 流動パラフィン 45.0 スクワラン 5.0 セスキオレイン酸ソルビタン 6.0 ポリオキシエチレン硬化ヒマシ油(20E.O.) 2.0 1,3−ブチレングリコール 5.0 パラオキシ安息香酸エステル 0.05 香 料 1.0 精製水 適 量 (製造方法)オレイルアルコール以下ポリオキシエチレ
ン硬化ヒマシ油までの5成分を加熱して均一に溶解す
る。次に、残る成分を加熱して均一に溶解して水相と
し、撹拌しながら前記油相に水相を加え均一に乳化し、
その後冷却して本発明の皮膚化粧料である乳液状の入浴
剤を得る。(Formulation Example 5) Bath Agent Ingredient Compounding Amount (% by Weight) Active Oxygen Species Elimination Agent of Example 1 1.0 Oleyl Alcohol 10.0 Liquid Paraffin 45.0 Squalane 5.0 Sorbitan Sesquioleate 6. 0 Polyoxyethylene hydrogenated castor oil (20 EO) 2.0 1,3-butylene glycol 5.0 Paraoxybenzoic acid ester 0.05 Fragrance 1.0 Purified water Appropriate amount (Production method) Oleyl alcohol or less polyoxy Heat and uniformly dissolve the five components up to ethylene-hardened castor oil. Next, the remaining components are heated and uniformly dissolved to form an aqueous phase, and the aqueous phase is added to the oil phase while stirring to emulsify uniformly,
Thereafter, the emulsion is cooled to obtain an emulsion bath agent which is the skin cosmetic of the present invention.
【0045】〔評価試験〕次に上記処方例1の乳液につ
いて、肌荒れを呈した女性20名(年齢23〜38才)
のパネラーに実際に使用してもらい、次の評価試験を行
った。なお、比較対照として、上記処方から活性酸素種
消去剤を除いて作製した乳液を用いた。[Evaluation Test] Next, 20 women (23-38 years of age) who exhibited rough skin with respect to the emulsion of Formulation Example 1 described above.
Were actually used by the panelists, and the following evaluation test was performed. As a comparative control, an emulsion prepared by removing the active oxygen species eliminating agent from the above formulation was used.
【0046】1.肌荒れ改善効果試験 18〜40才の女性を対象として、顔の皮膚表面形態を
シルフロ(Flexicl Developments
Ltd社製)によるレプリカ法を用いて肌のレプリカ
を取り、50倍のマイクロスコープにて観察を行い、皮
紋の状態及び角質剥離状態から、以下に示す評価基準に
基づいて、評価1又は2に該当する肌荒れと判定された
女性20名をパネラーに選定した。これら20名のパネ
ラーの顔面左右に、それぞれ処方例1の乳液と比較例の
乳液を朝夕各1回30日間塗布してもらった。30日後
に再び前記レプリカ法を用いて肌の状態を観察し、同評
価基準に従って、その改善度を評価した。1. Skin roughness improvement effect test For women aged 18 to 40 years, the surface skin morphology of the face was determined by Sylflo (Flexicl Developments).
A replica of the skin was taken using a replica method (Ltd. Ltd.), and observed with a microscope of 50 times magnification. Based on the evaluation criteria shown below, evaluation 1 or 2 was performed based on the skin crest state and the exfoliation state. Twenty women determined to have rough skin corresponding to were selected as panelists. The emulsion of Formulation Example 1 and the emulsion of Comparative Example were applied to the left and right faces of the face of these 20 panelists once each morning and evening for 30 days. After 30 days, the skin condition was observed again using the replica method, and the degree of improvement was evaluated according to the same evaluation criteria.
【0047】 (評価基準) 評 価 評 価 内 容 備 考 1 皮溝、皮丘が消失している。 肌荒れ 広範囲に角質層がめくれている。 2 皮溝、皮丘が不鮮明である。 肌荒れ 部分的に角質層がめくれている。 3 皮溝、皮丘が認められるが、平坦である。 普通肌 4 皮溝、皮丘が鮮明である。 比較的肌が きれい 5 皮溝、皮丘が極めて鮮明で整っている。 美しい肌(Evaluation Criteria) Evaluation Evaluation Contents Remarks 1 The skin sulcus and skin hills have disappeared. Rough skin The horny layer is turned up over a wide area. 2 Skin sulcus and skin ridge are unclear. Rough skin Partially turned up in the stratum corneum. 3 Skin sulcus and skin ridge are observed, but are flat. Normal skin 4 Skin grooves and skin hills are clear. Relatively clean skin 5 Skin grooves and skin ridges are extremely clear and well-organized. Beautiful skin
【0048】2.クスミ改善効果試験 上記肌荒れ改善効果試験に選定されたパネラー20名に
つき、各乳液塗布前と朝夕各1回30日間塗布した後の
クスミ改善効果を、メグザメーターMX−16(日本ユ
ーロテック社製)を用いて、肌のメラニン量、エリスマ
量を測定し、その数値変化によりクスミ改善効果を評価
した。評価方法は、各乳液の使用前後の測定値の比
〔(使用後の測定値/使用前の測定値)×100〕
(%)を算出し、以下に示す評価基準に基づいて、その
改善度を評価した。2. Miczameter MX-16 (manufactured by Eurotech Japan) was used for the 20 panelists selected for the skin roughness improvement effect test before and after applying each emulsion for 30 days each morning and evening. The amount of melanin and erythema in the skin was measured using the samples, and the change in the values was used to evaluate the effect of improving skin color. The evaluation method is the ratio of the measured values before and after use of each emulsion [(measured value after use / measured value before use) × 100]
(%) Was calculated, and the degree of improvement was evaluated based on the following evaluation criteria.
【0049】 (評価基準) 評 価 評 価 内 容 備 考 1 メラニン量、エリスマ量共に 改善効果が顕著 10%以上の低下 2 メラニン量、エリスマ量共に 改善効果がある 5〜10%の低下 3 メラニン量、エリスマ量共に 改善効果がややある 1〜5%の低下 4 メラニン量、エリスマ量と共に 改善効果がない 1%以下の低下(Evaluation Criteria) Evaluation Evaluation Contents Remarks 1 Remarkable improvement of both melanin and erythma. 10% or more reduction. 2 Improvement of both melanin and erythma. 5-10% reduction. 3 Melanin. There is a slight improvement in both the amount of erythema and the amount of erythema 1-5% decrease 4 There is no improvement effect with the amount of melanin and erythma 1% or less decrease
【0050】3.モニターによる使用感、使用効果の評
価試験 上記肌荒れ改善効果試験に選定されたパネラー20名に
対し、使用感と使用後の肌への効果について、下記に示
す項目についてアンケート調査を行った。3. Evaluation test of use feeling and use effect by monitor A questionnaire survey was conducted on the following items about the use feeling and the effect on the skin after use for 20 panelists selected in the above-mentioned skin roughness improvement effect test.
【0051】〔試験結果〕上記肌荒れ改善効果試験、ク
スミ改善効果試験及び使用感、使用効果の評価試験につ
いての試験結果をそれぞれ以下に示した。[Test Results] The test results of the above-described skin roughness improvement effect test, blemishes improvement effect test, and evaluation tests of the feeling of use and the effect of use are shown below.
【0052】 (荒れ改善効果試験) 評 価 塗布前の皮膚 実施例塗布後の皮膚 比較例塗布後の皮膚 1 8(名) 0(名) 6(名) 2 12 0 8 3 0 5 4 4 0 12 2 5 0 3 0(Roughness Improvement Effect Test) Evaluation Skin Before Application Skin After Application Example Skin After Application Comparative Example 18 (N) 0 (N) 6 (N) 2 12 0 8 3 0 5 4 4 0 12 25 0 30
【0053】 (クスミ改善効果試験) 評 価 実施例塗布 比較例塗布 1 3(名) 0(名) 2 9 1 3 6 11 4 2 8(Kusumi improvement effect test) Evaluation Example application Comparative example application 13 (name) 0 (name) 2 9 1 3 6 11 4 2 8
【0054】 (使用感、使用効果試験) 項 目 実施例をよしとした人数 比較例をよしとした人数 ・肌へのなじみ 13(名) 6(名) ・しっとり感 19 1 ・肌へののび 13 5 ・肌荒れ改善の 18 0 満足感 ・肌色改善の 13 4 満足感 ・シワの数、深さ 16 2 改善効果 なお、合計が20名とならない項目については、両者同
じ程度と解答していた。(Use feeling, use effect test) Item Number of people who made the example better Number of people who made the comparative example better ・ Familiarity to skin 13 (N) 6 (Person) ・ Moist feeling 19 1 ・ Stretch to skin 13 5 -180 satisfaction for improvement of rough skin-134 satisfaction for improvement of skin color-Number and depth of wrinkles 16 2 Improvement effect For items that did not add up to 20 persons, they answered that they were about the same.
【0055】上記結果から分かるように、本発明の皮膚
化粧料にあっては、肌荒れやクスミについて顕著な改善
効果が見られ、また、実際の使用感についても比較例に
比べて優れたものであることが確認された。As can be seen from the above results, the skin cosmetic of the present invention has a remarkable improvement effect on rough skin and dark spots, and the actual feeling of use is superior to that of the comparative example. It was confirmed that there was.
【0056】もちろん、本発明は上記実施例に限定され
るものでなく、赤米玄米及び/又は赤米玄米を精米して
得られる糠より、種々の親水性有機溶媒を用いて本発明
の活性酸素種消去剤を得ることができ、また、当該活性
酸素種消去剤は、様々の食品や皮膚化粧料等広範囲に用
いることができるのは言うまでもない。Needless to say, the present invention is not limited to the above Examples, and the activity of the present invention can be improved by using various hydrophilic organic solvents from red rice brown rice and / or bran obtained by polishing red rice brown rice. It is needless to say that an oxygen species scavenger can be obtained, and the active oxygen species scavenger can be used in a wide range of foods and skin cosmetics.
【0057】[0057]
【発明の効果】本発明によれば、活性酸素種消去活性が
極めて高く、しかも安全性の高い従来にない全く新規の
活性酸素種消去剤を提供できる。この結果、日焼け等の
外的刺激による皮膚の肌荒れ、シワ、シミ、クスミ及び
色素の異常沈着等皮膚の老化を予防又は改善する効果に
優れた皮膚化粧料等を提供できる。According to the present invention, it is possible to provide an entirely new active oxygen species scavenger which has extremely high active oxygen species scavenging activity and high safety. As a result, it is possible to provide a skin cosmetic or the like having an excellent effect of preventing or improving skin aging such as rough skin, wrinkles, spots, dark spots and abnormal deposition of pigments due to external stimuli such as sunburn.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA111 AA112 AA122 AB032 AB442 AC022 AC072 AC082 AC122 AC182 AC242 AC302 AC402 AC422 AC432 AC442 AC482 AC582 AD092 AD152 AD222 AD352 AD662 BB51 CC04 CC05 CC07 CC25 DD23 DD27 DD31 EE11 EE12 EE13 EE16 EE41 4C088 AB74 AC04 AC14 BA08 BA10 MA07 MA63 NA14 ZA89 ZC21 ──────────────────────────────────────────────────続 き Continued on front page F-term (reference) 4C083 AA111 AA112 AA122 AB032 AB442 AC022 AC072 AC082 AC122 AC182 AC242 AC302 AC402 AC422 AC432 AC442 AC482 AC582 AD092 AD152 AD222 AD352 AD662 BB51 CC04 CC05 CC07 CC25 DD23 DD27 DD31 EE11 EE12 EE4 4 AB74 AC04 AC14 BA08 BA10 MA07 MA63 NA14 ZA89 ZC21
Claims (3)
得られる糠より、親水性有機溶媒又はこれらと水との混
合溶媒を用いて得られる抽出物を含有することを特徴と
する活性酸素種消去剤。The present invention is characterized in that it comprises a hydrophilic organic solvent or an extract obtained by using a mixed solvent of these with water from red rice brown rice and / or bran obtained by polishing red rice brown rice. Reactive oxygen species scavenger.
ル、エチルアルコール、グリセリン、プロピレングリコ
ール、1,3−ブチレングリコール、ジプロピレングリ
コール、イソプレングリコールである請求項1記載の活
性酸素種消去剤。2. The active oxygen species scavenger according to claim 1, wherein the hydrophilic organic solvent is methyl alcohol, ethyl alcohol, glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, or isoprene glycol.
が配合されたことを特徴とする皮膚化粧料。3. A skin cosmetic comprising the active oxygen species scavenger according to claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10211611A JP2000044485A (en) | 1998-07-27 | 1998-07-27 | Active oxygen species scavenger and skin cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10211611A JP2000044485A (en) | 1998-07-27 | 1998-07-27 | Active oxygen species scavenger and skin cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000044485A true JP2000044485A (en) | 2000-02-15 |
Family
ID=16608637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10211611A Pending JP2000044485A (en) | 1998-07-27 | 1998-07-27 | Active oxygen species scavenger and skin cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000044485A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002003393A (en) * | 2000-06-26 | 2002-01-09 | Maruzen Pharmaceut Co Ltd | Fibroblast growth agent, food and drink for beauty culture and skin cosmetic |
| JP2002029926A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Agent for reconstruction of structure of cutis collagen fascicle and composition including the same |
| JP2002255784A (en) * | 2001-03-02 | 2002-09-11 | Oriza Yuka Kk | Composition for beautiful skin |
| JP2004099578A (en) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | Composition for beautiful skin |
| JP2004099503A (en) * | 2002-09-09 | 2004-04-02 | Nonogawa Shoji Kk | Hgf production promoter and cosmetic containing the same |
| JP2004520305A (en) * | 2000-12-20 | 2004-07-08 | エル・ジー ハウスホールド アンド ヘルスケア リミティッド | Composition for prevention and reduction of skin wrinkles |
| JP2005015450A (en) * | 2003-06-30 | 2005-01-20 | Kanebo Cosmetics Inc | Skin cosmetics |
| JP2005281151A (en) * | 2004-03-29 | 2005-10-13 | Nof Corp | Bath salt and method for producing the same |
| JP2007223990A (en) * | 2006-02-27 | 2007-09-06 | Chikuno Shokuhin Kogyo Kk | Antioxidant composition |
| JP4763460B2 (en) * | 2003-08-22 | 2011-08-31 | 株式会社コーセー | Singlet oxygen scavenger and composition using the same |
| JP2011213658A (en) * | 2010-03-31 | 2011-10-27 | Naris Cosmetics Co Ltd | Antioxidant, ultraviolet hazard inhibitor and anti-photoageing cosmetic |
| KR101217704B1 (en) * | 2010-08-18 | 2013-01-02 | 영남대학교 산학협력단 | Cosmetic composition for skin whitening comprising red rice extract |
| JP2013249265A (en) * | 2012-05-30 | 2013-12-12 | Bloom Classic Co Ltd | Whitening agent and skin cosmetic |
| WO2019198743A1 (en) * | 2018-04-10 | 2019-10-17 | 株式会社Stardust Hd. | Composition comprising citrus junos seed extract and brown rice extract |
| JP2020063219A (en) * | 2018-10-19 | 2020-04-23 | 株式会社ナリス化粧品 | Dermis spots improver |
-
1998
- 1998-07-27 JP JP10211611A patent/JP2000044485A/en active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002003393A (en) * | 2000-06-26 | 2002-01-09 | Maruzen Pharmaceut Co Ltd | Fibroblast growth agent, food and drink for beauty culture and skin cosmetic |
| JP2002029926A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Agent for reconstruction of structure of cutis collagen fascicle and composition including the same |
| JP2004520305A (en) * | 2000-12-20 | 2004-07-08 | エル・ジー ハウスホールド アンド ヘルスケア リミティッド | Composition for prevention and reduction of skin wrinkles |
| JP2002255784A (en) * | 2001-03-02 | 2002-09-11 | Oriza Yuka Kk | Composition for beautiful skin |
| JP2004099578A (en) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | Composition for beautiful skin |
| JP2004099503A (en) * | 2002-09-09 | 2004-04-02 | Nonogawa Shoji Kk | Hgf production promoter and cosmetic containing the same |
| JP2005015450A (en) * | 2003-06-30 | 2005-01-20 | Kanebo Cosmetics Inc | Skin cosmetics |
| JP4763460B2 (en) * | 2003-08-22 | 2011-08-31 | 株式会社コーセー | Singlet oxygen scavenger and composition using the same |
| JP2005281151A (en) * | 2004-03-29 | 2005-10-13 | Nof Corp | Bath salt and method for producing the same |
| JP2007223990A (en) * | 2006-02-27 | 2007-09-06 | Chikuno Shokuhin Kogyo Kk | Antioxidant composition |
| JP2011213658A (en) * | 2010-03-31 | 2011-10-27 | Naris Cosmetics Co Ltd | Antioxidant, ultraviolet hazard inhibitor and anti-photoageing cosmetic |
| KR101217704B1 (en) * | 2010-08-18 | 2013-01-02 | 영남대학교 산학협력단 | Cosmetic composition for skin whitening comprising red rice extract |
| JP2013249265A (en) * | 2012-05-30 | 2013-12-12 | Bloom Classic Co Ltd | Whitening agent and skin cosmetic |
| WO2019198743A1 (en) * | 2018-04-10 | 2019-10-17 | 株式会社Stardust Hd. | Composition comprising citrus junos seed extract and brown rice extract |
| JP6651084B1 (en) * | 2018-04-10 | 2020-02-19 | 株式会社Stardust Hd. | Composition containing extract of yuzu seed and brown rice |
| CN111246869A (en) * | 2018-04-10 | 2020-06-05 | 日商星尘股份有限公司 | Composition containing extracts of Citrus aurantium seed and brown rice |
| KR20200121365A (en) * | 2018-04-10 | 2020-10-23 | 가부시키가이샤 스타더스트 에이치디. | Composition containing extracts of citron seeds and brown rice |
| KR102263581B1 (en) | 2018-04-10 | 2021-06-11 | 가부시키가이샤 스타더스트 에이치디. | Composition containing extracts of citron seeds and brown rice |
| US11850272B2 (en) | 2018-04-10 | 2023-12-26 | Stardust Hd, Inc. | Composition comprising yuzu seed extract and brown rice extract |
| JP2020063219A (en) * | 2018-10-19 | 2020-04-23 | 株式会社ナリス化粧品 | Dermis spots improver |
| JP7184593B2 (en) | 2018-10-19 | 2022-12-06 | 株式会社ナリス化粧品 | Dermal blemish improver |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4025546B2 (en) | Skin beautifying agent, skin anti-aging agent, whitening agent and skin external preparation | |
| JP2002193738A (en) | Use of at least one extract of at least one rhododendron in a composition for treating the signs of skin aging | |
| JP2000044485A (en) | Active oxygen species scavenger and skin cosmetic | |
| JP2000128765A (en) | Skin cosmetic | |
| JP2004189698A (en) | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, skin external preparations, cosmetics and foodstuffs | |
| KR102063686B1 (en) | Skin external composition containing extract of soybean root | |
| JP3608078B2 (en) | Collagen production promoter, estrogenic agent, skin cosmetic and beauty food | |
| KR100888753B1 (en) | Composition comprising an extract of Cornus kousa or the compounds isolated therefrom having anti-aging and anti-wrinkle activity | |
| JP3933511B2 (en) | Skin cosmetics and beauty food and drink | |
| KR100882744B1 (en) | Manufacturing method of cosmetic composition containing extract | |
| KR20080098925A (en) | Cosmetic composition containing extract of the bark | |
| CN107648087B (en) | Whitening antioxidant skin cream and preparation method thereof | |
| JP2001122733A (en) | Catalase production-promoting preparation and skin preparation for external use containing the same | |
| JP2002302452A (en) | Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger | |
| JP3827581B2 (en) | Skin cosmetics and beauty food and drink | |
| JP3889894B2 (en) | Antiallergic agents, whitening agents and skin cosmetics | |
| US20130028849A1 (en) | Agent For Stimulating The Expression of Loxl | |
| JP4202638B2 (en) | Collagen production promoter, elastase inhibitor, collagenase inhibitor and anti-aging skin cosmetic | |
| JP4247091B2 (en) | Skin anti-aging agent | |
| KR20090097550A (en) | Suzandrarin and cosmetic composition containing this extract as an active ingredient | |
| KR100525722B1 (en) | Topical constituents of ginsenoside Rh2 and ginsenoside Rg3 | |
| JP2003055245A (en) | Skin cosmetic and food and beverage | |
| JPH10236941A (en) | Skin lotion | |
| JP2002053477A (en) | Skin care preparation | |
| JPH11171722A (en) | Preparation for external use for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050524 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090210 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090413 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090526 |